Aradigm Regains Compliance with NASDAQ Listing Requirements

07:00 EDT 10 Oct 2017 | Businesswire
This article has expired, however you can still download the PDF.
Aradigm Corporation (Nasdaq:ARDM) (“Aradigm" or the “Company”) today announced that it received notice from The NASDAQ Capital Market (“NASDAQ”) indicating that the Company has regained compliance under NASDAQ Listing ...

Other Sources for this Article

Aradigm Corporation
Nancy Pecota, 510-265-8800
Chief Financial Officer


More From BioPortfolio on "Aradigm Regains Compliance with NASDAQ Listing Requirements"

Quick Search


Relevant Topics

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...